ESAB Corporation stocks have been trading up by 10.73 percent after upbeat earnings and guidance strengthened investor confidence
Click Here for a Millionaire's POV on Trading ESAB
SUBSCRIBE FOR ALERTSJOIN 50,000+ ACTIVE TRADERS
What Traders Need To Know
- Shares have dropped about 19% since the Iran war, but multiple brokers still rate ESAB Corporation (ESAB) Buy/Outperform with upside to their lowered price targets.
- Management reaffirmed 2026 guidance for 6%–9% organic core sales growth, EBITDA, and EPS despite geopolitical and macro headwinds.
- A CFO transition brings in veteran finance leader R. Brent Jones while ESAB keeps its medium-term financial targets intact.
- Oppenheimer expects a second-half EPS inflection helped by the Eddyfi acquisition and potential Middle East reconstruction demand.
- Q1 2026 earnings and the conference call will be the next key test of whether reaffirmed guidance still holds.
Weekly Update Apr 13 – Apr 17, 2026: On Friday, April 17, 2026 ESAB Corporation stock [NYSE: ESAB] is trending up by 10.73%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Industrials industry expert:
Analyst sentiment – positive
ESAB holds a solid global welding and cutting position with attractive fundamentals. Mid-teens EBITDA margin (15.1%) and ~12% EBIT margin place it at the high end of Industrials peers, supported by a 36.9% gross margin and disciplined cost control. Returns (ROE ~12.5%, ROIC ~7–11%) are respectable but have room to improve as recent M&A synergies mature. Balance sheet strength is a clear positive: net leverage is moderate (D/E 0.57, interest coverage 25.6x, current ratio 1.9), enabling continued bolt-on deals and shareholder returns. Free cash flow conversion is robust (FCF of ~$77m in Q4 vs. $89m EBITDA) with low capital intensity and a conservative sub-0.5% dividend yield, suggesting capital is prioritized toward growth and deleveraging rather than income.
Technically, ESAB is attempting to reassert an uptrend after a sharp, news-driven drawdown. This week’s range from roughly $99 to $110 shows strong dip buying, with the latest close at $109.55 reclaiming prior breakdown levels and confirming support in the high-$90s. Intraday 5-minute action shows rising lows and heavier volume on green candles, pointing to accumulation. The key actionable level is $100: above it, risk-reward favors long positions, with a tight stop just below $98 to respect the recent volatility and preserve capital.
More Breaking News
- MSTR Stock Draws Bulls As Bitcoin Treasury Pushes Higher
- FLY Stock Rallies As AI Lunar Mission Fuels Momentum
- USAR Stock Rallies As Mine‑To‑Magnet Story Gains Traction
- ROAD Surges As Construction Partners Wins Upgrade And Expands In Nashville
Fundamentally and on news flow, ESAB screens better than the broader Industrials and Industrial Goods complexes, which generally show lower structural margins and less consistent capital allocation. Street remains firmly constructive with clustered Buy/Overweight ratings and price targets around $135–$142, even after war-related estimate trims. Reaffirmed 2026 guidance, an accretive Eddyfi acquisition, and a seasoned new CFO underpin a credible EPS acceleration into 2027. I see asymmetric upside with a 12–18 month target of $135, key support at $98–100, and resistance in the $120–125 zone.
Quick Financial Overview
ESAB Corporation (ESAB) is trading around the low $100s after a sharp pullback tied to the Iran conflict, with Oppenheimer noting roughly a 19% drawdown from prior levels. The recent weekly data show ESAB bouncing from about $99 to a $109.55 close, signaling buyers stepping in near psychological support around $100. Intraday, the stock held a tight band mostly between $109 and $110, with closing prints hugging the upper half of the day’s range, which points to steady demand into the bell.
On the fundamentals, ESAB generated about $2.84B in revenue over the last year, with a solid 36.9% gross margin and 15.1% EBITDA margin. Profitability metrics are healthy for an industrial name: EBIT margin is 12.1% and return on equity sits in the low double digits. The balance sheet is manageable, with total debt to equity around 0.57, interest coverage at 25.6, and a current ratio of 1.9, giving ESAB room to handle macro noise while funding growth.
Valuation is not dirt cheap but reasonable for a quality compounder, with a price-to-sales near 2.2 and a P/E around 25.5, against a history that has ranged roughly 12.5–41. Free cash flow of about $77.4M in the latest quarter supports a modest dividend (about $0.40 per year, roughly a 0.4% yield) and ongoing deleveraging. For traders, this setup combines decent growth, resilient margins, and a clean balance sheet with a chart that has corrected hard and is now trying to base.
Conclusion
This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.
Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.
Check out our quick startup guide for new traders!
- How to Read Stock Charts: A Guide for Beginners
- Trading Plan: 6 Steps to Create One
- How To Create a Stock Watchlist
Ready to build your watchlists? Check out these curated lists:
Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.